Multiple Tests with Single Small Blood Sample

Affordable, Accurate, Efficient and Flexible



The PictArray™ SARS-CoV-2 antibody test separately identifies antibodies from vaccines and COVID-19 infection in one test and is now available for doctors and patients who would like to gain insight:

  • Whether there is an immune response to vaccination.
  • Whether or not there has been a previous SARS-CoV-2 infection and if there are antibodies developed against the virus
  • To identify at-risk individuals who do not have a detectable SaRS-CoV-2 antibody response despite having been previously vaccinated or infected.


Detection Addition Control Spots
SARS-CoV-2 NP IgG Antibody detection spots 
SARS-CoV-2 SP IgG Antibody detection spots 
Blank Control Spots

Detects both Spike and Nucleocapsid proteins

Sample size is 1:101 serum dilution

Download Instructions For Use (IFU)


Expressions of interest in LDTs welcome.



ToRCH describes a group of clinically similar congenital infections caused by Toxoplasma gondii, Rubella, Cytomegalovirus (CMV) and Herpes simplex virus 1 and 2 (HSV)

Infections with one or more of these pathogens during pregnancy can have devastating consequences for the infant.

Pregnant women in developing countries are commonly tested for antibodies to ToRCH antigens during the first two trimesters of pregnancy.

Detection Addition Control Spots
Sample Addition Control
Conjugate G/M Addition Control
Conjugate M Addition Control
Blank Control Spots
Toxoplasma Gondii
Cytomegalovirus (CMV)
Herpes Simplex Virus 1 (HSV 1)
Herpes Simplex Virus 2 (HSV 2)

Detects IgG/IgM antibodies
Requires only 5–10µl serum sample
Sensitivity ≥ 90% & Specificity ≥ 95%
Shelf Life–13 months

Download Instructions For Use (IFU)

PICT_TRH_01 (16 Tests)
PICT_TRH_03 (48 Tests)
PICT_TRH_06 (96 Tests)

en_NZEnglish (New Zealand)